Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Depreciation & Amortization (CF) (2016 - 2025)

Lipocine (LPCN) has disclosed Depreciation & Amortization (CF) for 12 consecutive years, with $14123.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization (CF) rose 65.94% year-over-year to $14123.0, compared with a TTM value of $61372.0 through Sep 2025, up 82.99%, and an annual FY2024 reading of $41106.0, up 43.42% over the prior year.
  • Depreciation & Amortization (CF) was $14123.0 for Q3 2025 at Lipocine, down from $16108.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $16108.0 in Q2 2025 and bottomed at $1719.0 in Q1 2022.
  • Average Depreciation & Amortization (CF) over 4 years is $8334.7, with a median of $8091.0 recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) surged 213.85% in 2023, then rose 5.2% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $2578.0 in 2022, then surged by 210.43% to $8003.0 in 2023, then soared by 94.56% to $15571.0 in 2024, then decreased by 9.3% to $14123.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for LPCN at $14123.0 in Q3 2025, $16108.0 in Q2 2025, and $15570.0 in Q1 2025.